ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.

Hong Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.